![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | RANBP3L | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Ranbp3l (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RANBP3L mRNA | CTD | PMID:36331819 | RANBP3L | Human | 1,1-dichloroethene | decreases expression | ISO | Ranbp3l (Mus musculus) | 6480464 | vinylidene chloride results in decreased expression of RANBP3L mRNA | CTD | PMID:26682919 | RANBP3L | Human | 1,2-dichloroethane | increases expression | ISO | Ranbp3l (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of RANBP3L mRNA | CTD | PMID:28960355 | RANBP3L | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of RANBP3L mRNA | CTD | PMID:22298810 | RANBP3L | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ranbp3l (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of RANBP3L mRNA | CTD | PMID:21570461 and PMID:26377647 | RANBP3L | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of RANBP3L mRNA | CTD | PMID:26159488 | RANBP3L | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Ranbp3l (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RANBP3L mRNA | CTD | PMID:21724226 | RANBP3L | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ranbp3l (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of RANBP3L mRNA | CTD | PMID:22298810 | RANBP3L | Human | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | ISO | Ranbp3l (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | RANBP3L | Human | acrylamide | decreases expression | ISO | Ranbp3l (Rattus norvegicus) | 6480464 | Acrylamide results in decreased expression of RANBP3L mRNA | CTD | PMID:28959563 | RANBP3L | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of RANBP3L gene | CTD | PMID:27153756 | RANBP3L | Human | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of RANBP3L mRNA | CTD | PMID:27829220 | RANBP3L | Human | atrazine | affects methylation | ISO | Ranbp3l (Rattus norvegicus) | 6480464 | Atrazine affects the methylation of RANBP3L gene | CTD | PMID:35440735 | RANBP3L | Human | benzo[a]pyrene | decreases expression | ISO | Ranbp3l (Rattus norvegicus) | 6480464 | Benzo(a)pyrene results in decreased expression of RANBP3L mRNA | CTD | PMID:21839799 | RANBP3L | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of RANBP3L exon | CTD | PMID:30157460 | RANBP3L | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of RANBP3L exon and Benzo(a)pyrene results in increased methylation of RANBP3L promoter | CTD | PMID:27901495 | RANBP3L | Human | benzo[a]pyrene | increases expression | ISO | Ranbp3l (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of RANBP3L mRNA | CTD | PMID:20127859 and PMID:22228805 | RANBP3L | Human | benzo[a]pyrene | multiple interactions | ISO | Ranbp3l (Mus musculus) | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of RANBP3L mRNA] | CTD | PMID:22228805 | RANBP3L | Human | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Ranbp3l (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of RANBP3L promoter | CTD | PMID:23359474 | RANBP3L | Human | bisphenol A | multiple interactions | ISO | Ranbp3l (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of RANBP3L promoter | CTD | PMID:23359474 | RANBP3L | Human | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of RANBP3L gene | CTD | PMID:31601247 | RANBP3L | Human | bisphenol A | decreases expression | ISO | Ranbp3l (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of RANBP3L mRNA | CTD | PMID:25181051 and PMID:38750585 | RANBP3L | Human | bisphenol F | decreases expression | ISO | Ranbp3l (Mus musculus) | 6480464 | bisphenol F results in decreased expression of RANBP3L mRNA | CTD | PMID:38685157 | RANBP3L | Human | butanal | increases expression | EXP | | 6480464 | butyraldehyde results in increased expression of RANBP3L mRNA | CTD | PMID:26079696 | RANBP3L | Human | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of RANBP3L mRNA | CTD | PMID:38568856 | RANBP3L | Human | capsaicin | increases expression | ISO | Ranbp3l (Rattus norvegicus) | 6480464 | Capsaicin results in increased expression of RANBP3L mRNA | CTD | PMID:20349343 | RANBP3L | Human | dexamethasone | decreases expression | ISO | Ranbp3l (Mus musculus) | 6480464 | Dexamethasone results in decreased expression of RANBP3L mRNA | CTD | PMID:22733784 | RANBP3L | Human | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of RANBP3L mRNA | CTD | PMID:27829220 | RANBP3L | Human | dibutyl phthalate | multiple interactions | ISO | Ranbp3l (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of RANBP3L promoter | CTD | PMID:23359474 | RANBP3L | Human | endosulfan | multiple interactions | EXP | | 6480464 | [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of RANBP3L mRNA | CTD | PMID:26159488 | RANBP3L | Human | epoxiconazole | affects expression | ISO | Ranbp3l (Mus musculus) | 6480464 | epoxiconazole affects the expression of RANBP3L mRNA | CTD | PMID:35436446 | RANBP3L | Human | folic acid | decreases expression | ISO | Ranbp3l (Mus musculus) | 6480464 | Folic Acid results in decreased expression of RANBP3L mRNA | CTD | PMID:25629700 | RANBP3L | Human | furan | increases expression | ISO | Ranbp3l (Rattus norvegicus) | 6480464 | furan results in increased expression of RANBP3L mRNA | CTD | PMID:25539665 | RANBP3L | Human | glycine betaine | decreases expression | ISO | Ranbp3l (Rattus norvegicus) | 6480464 | Betaine results in decreased expression of RANBP3L mRNA | CTD | PMID:26391144 | RANBP3L | Human | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RANBP3L mRNA | CTD | PMID:35811015 | RANBP3L | Human | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of RANBP3L mRNA | CTD | PMID:35811015 | RANBP3L | Human | N-nitrosodiethylamine | multiple interactions | ISO | Ranbp3l (Mus musculus) | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of RANBP3L mRNA | CTD | PMID:24535843 | RANBP3L | Human | N-nitrosodiethylamine | decreases expression | ISO | Ranbp3l (Mus musculus) | 6480464 | Diethylnitrosamine results in decreased expression of RANBP3L mRNA | CTD | PMID:24535843 | RANBP3L | Human | nitrofen | decreases expression | ISO | Ranbp3l (Rattus norvegicus) | 6480464 | nitrofen results in decreased expression of RANBP3L mRNA | CTD | PMID:33484710 | RANBP3L | Human | paraquat | decreases expression | ISO | Ranbp3l (Rattus norvegicus) | 6480464 | Paraquat results in decreased expression of RANBP3L mRNA | CTD | PMID:32680482 | RANBP3L | Human | perfluorohexanesulfonic acid | increases expression | ISO | Ranbp3l (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of RANBP3L mRNA | CTD | PMID:37995155 | RANBP3L | Human | perfluorononanoic acid | decreases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of RANBP3L mRNA | CTD | PMID:32588087 | RANBP3L | Human | perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of RANBP3L mRNA | CTD | PMID:32588087 | RANBP3L | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Ranbp3l (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RANBP3L mRNA | CTD | PMID:36331819 | RANBP3L | Human | phenobarbital | multiple interactions | ISO | Ranbp3l (Mus musculus) | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of RANBP3L mRNA | CTD | PMID:24535843 | RANBP3L | Human | pirinixic acid | decreases expression | ISO | Ranbp3l (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of RANBP3L mRNA | CTD | PMID:23811191 | RANBP3L | Human | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RANBP3L mRNA | CTD | PMID:35811015 | RANBP3L | Human | silicon dioxide | decreases expression | ISO | Ranbp3l (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of RANBP3L mRNA | CTD | PMID:29203145 | RANBP3L | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of RANBP3L mRNA | CTD | PMID:29301061 | RANBP3L | Human | trovafloxacin | decreases expression | ISO | Ranbp3l (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of RANBP3L mRNA | CTD | PMID:35537566 | RANBP3L | Human | zoledronic acid | decreases expression | EXP | | 6480464 | zoledronic acid results in decreased expression of RANBP3L mRNA | CTD | PMID:24714768 | |